Status:
UNKNOWN
Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial
Lead Sponsor:
Cairo University
Conditions:
Onychomycosis of Fingernail
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Our aim is to assess the clinical efficacy and the safety of fractional CO2 laser combined with topical tioconazole versus Q-switched Nd:YAG laser in the treatment of OM.
Eligibility Criteria
Inclusion
- • Age group \>18 years.
- Patients of both genders.
- Patients with OM any type.
Exclusion
- • Pregnancy
- Localized bacterial infection around the affected nail
- Concomitant nails disease that causes nail dystrophy or discoloration such as psoriasis, lichen planus and atopic dermatitis that may interfere with diagnosis and treatment
- Hypersensitivity to terbinafine
- Intake of oral antifungal medication within the last 3 months or used topical antifungal medication within the last 2 weeks prior to the laser treatment
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05999474
Start Date
September 1 2022
End Date
October 1 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy Faculty of Medicine
Cairo, Egypt